Pluristem Therapeutics Inc.


Pluristem is a clinical-stage regenerative medicine company that is using placental cells and a proprietary three-dimensional (3D) technology platform for developing cell therapies for ailments such as inflammation, muscle injuries, hematological disorders, and radiation exposure.


Founded 2003
Type Public
Location Haifa, Israel


PLUR $0.78 3.48% $0.03

Latest News

Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost Reduction in line with New Strategy and Financial Updates Sep 29, 2022 GlobeNewswire Inc. HAIFA, Israel, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a...